Versartis Inc Email Formats

Pharmaceutical Manufacturing • Menlo Park, California, United States • 1-10 Employees

Key Contact at Versartis Inc

John Kotek

Sr. Director

Company overview

Headquarters	4200 BOHANNON DR, Menlo Park, California 94025, us
Website	versartis.com
NAICS	3254
Founded	2008
Employees	1-10

About Versartis Inc

Versartis, Inc. is an endocrine-focused biopharmaceutical company. The Company is engaged in developing a long-acting form of recombinant human growth hormone, somavaratan (VRS-317), for growth hormone deficiency (GHD), an orphan disease. The Company's first indication for somavaratan is pediatric GHD. The Company may develop somavaratan for additional growth disorders, such as idiopathic short stature (ISS), small for gestational age (SGA) and Turner Syndrome. Somavaratan is engineered using XTEN technology to extend the residence time in the bloodstream by reducing the clearance of recombinant human growth hormone (rhGH) from the body by the two primary mechanisms, kidney filtration and receptor mediated clearance.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Senior

Funding Data

Versartis Inc has never raised funding before.

Frequently asked questions

Versartis Inc is located in Menlo Park, California, US.

Versartis Inc was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

Versartis Inc has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Versartis Inc

John Kotek

Sr. Director

4.8

40,000 users